Oxynorm Concentrado (Oxycodone Hydrochloride)

Oxycodone hydrochloride, the active ingredient in Oxynorm Concentrado, is an opioid analgesic presented as a concentrated oral formulation for systemic use. It is indicated for the management of moderate to severe pain in adult patients when other analgesics are insufficient. GNH USA supplies Oxynorm Concentrado as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxynorm Concentrado as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxynorm Concentrado is an opioid analgesic used in the management of pain through central nervous system pathways.

- Acute postoperative pain: provides rapid relief following surgical procedures. - Cancer‑related pain: helps control persistent pain associated with malignant disease. - Severe chronic non‑cancer pain: used when other analgesics fail to achieve adequate control. - Pain in palliative care: improves comfort for patients with life‑limiting illnesses.

Oxycodone may cause a range of adverse reactions, from mild to potentially life‑threatening.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Nausea and vomiting: stimulation of the chemoreceptor trigger zone. - Drowsiness: central nervous system depression. - Dry mouth: decreased salivary secretion. - Dizziness: orthostatic hypotension. - Pruritus: histamine release.

Serious or Rare Side Effects: - Respiratory depression: reduced respiratory drive, especially at high doses. - Severe hypotension: marked drop in blood pressure. - Seizures: rare central nervous system events. - Allergic reactions: rash, angio‑edema, anaphylaxis. - Dependence and withdrawal: risk of physical and psychological dependence. - Adrenal insufficiency: rare endocrine disturbance.

When prescribing Oxynorm Concentrado, clinicians should consider patient‑specific factors and safety measures.

- Assess pain severity and prior opioid use: ensure appropriate indication. - Evaluate respiratory function: avoid use in patients with compromised breathing. - Review concomitant CNS depressants: monitor for additive sedation. - Monitor for signs of dependence: educate patients on risks. - Adjust dose in renal or hepatic impairment: use lower initial doses. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Oxynorm Concentrado can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Benzodiazepines: combined CNS depression can cause profound respiratory depression. - Barbiturates: additive sedative effects increase risk of overdose. - Muscle relaxants: heightened risk of profound sedation and respiratory compromise.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may increase serotonin levels and risk of serotonin syndrome. - Antihistamines: can enhance drowsiness and dizziness. - CYP3A4 inhibitors (e.g., ketoconazole): may raise oxy‑cocaine   ...